Month: August 2025
Asia-Pacific markets trade mixed, breaking ranks from Wall Street gains
The Seoul skyline. Mongkol Chuewong | Moment | Getty Images Asia-Pacific markets traded mixed on Friday, breaking ranks from Wall Street gains as investors also assess a slate of economic data in the region. Japan’s Nikkei 225 slid 0.31%, while the Topix lost 0.39% after core consumer prices in Tokyo rose at a slower pace in […]
Read More
Affirm’s stock soars 15% on earnings, revenue beat
Key Points Affirm reported earnings per share of 20 cents for the quarter, almost double what analysts expected. The company also reported better-than-expected revenue. Source
Read More
Stock futures are little changed after S&P 500’s record high, inflation data looms: Live updates
Traders work at the New York Stock Exchange on August 20, 2025. NYSE U.S. equity futures were little changed on Thursday evening, after the S&P 500 registered a fresh record driven by renewed optimism around the artificial intelligence trade. Futures tied to the Dow Jones Industrial Average slipped 62 points, or 0.1%. S&P 500 futures […]
Read More
Feds charge ‘Subway’ sandwich tosser with misdemeanor after grand jury balks at felony indictment
A person walks past art work depicting former DOJ employee Sean Charles Dunn is displayed against a restaurant wall on August 17, 2025 in the Adams Morgan neighborhood of Washington. Tom Brenner | The Washington Post | Getty Images Prosecutors have charged the man accused of throwing a “Subway” sandwich at a federal officer on […]
Read More
Tesla FSD turns off more U.S. consumers than its attracts, survey finds
Elon Musk reacts during a press event with U.S. President Donald Trump (not pictured), at the White House in Washington, D.C., U.S., May 30, 2025. Nathan Howard | Reuters Elon Musk’s fervent promotion of Tesla‘s self-driving technology isn’t doing much to win over prospective buyers. According to a new survey, more U.S. consumers say that […]
Read More
Stocks making the biggest moves after hours: Ulta Beauty, Dell Technologies, Gap, Autodesk and more
Check out the companies making headlines in extended trading. Ulta Beauty — The cosmetics and beauty products retailer surged about 6% after raising its full-year earnings and revenue forecast. Ulta expects full-year revenue of $12 billion to $12.1 billion, above the $11.7 billion estimate from analysts polled by LSEG. Ulta expects full-year earnings of $23.85 […]
Read More
Ulta Beauty raises full-year forecast after reporting growth in all major categories
Ulta Beauty on Thursday raised its full-year forecast, after reporting growth in all major categories and topping Wall Street’s quarterly sales expectations. The beauty retailer said it expects net sales of between $12 billion and $12.1 billion, up from its previous range of $11.5 billion and $11.7 billion, representing an increase from last fiscal year’s […]
Read More
Gap stock falls as retailer misses sales expectations, driven by decline at Athleta
Gap’s fiscal second-quarter revenue came in lighter than expected on Thursday but sales at Banana Republic far exceeded expectations as the brand’s turnaround begins to show results. The specialty apparel company behind Old Navy, Athleta, Banana Republic and its namesake banner saw comparable sales rise 1% during the quarter, weaker than the 1.9% rise that […]
Read More
Dell shares fall on soft third-quarter earnings outlook
A Dell Technologies sign is seen in Round Rock, Texas, on June 2, 2023. Brandon Bell | Getty Images Despite beating on its top and bottom lines, shares of Dell Technologies fell more than 5% Thursday in extended trading after giving third-quarter earnings per share guidance that below Wall Street’s expectations. Here’s how the systems […]
Read More
The vaccine and public health debate at the center of CDC upheaval, explained
The exterior of the Center for Disease Control and Prevention (CDC) main campus in Atlanta, Georgia, U.S., Aug. 27, 2025. Alyssa Pointer | Reuters The Centers for Disease Control and Prevention is facing a leadership upheaval — and at the center of the shakeup is concern about the agency’s approach to vaccines and U.S. public […]
Read More